Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

Investors' focus is likely to be on the performance of Dupixent and the uptake of Eylea HD when REGN reports fourth-quarter ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular edema ...

Hello and welcome to this video series sponsored by Bayer in which we are going to explore Eylea 8 mg for the treatment of age-related macular degeneration and diabetic macular edema. I am Professor ...

MG is a brand that’s rapidly on the up. Between 2021 and 2023, it has seen a hefty 64 per cent growth in its sales, lifting the brand from 18,000 sales in 2020 to 81,000 last year. Cars like ...

After many months, if not years, of leaks and speculation, it’s finally official: Nintendo has announced its next console, and it’s called Nintendo Switch 2. As the name implies, it’s a very ...

Speaking to The Straits Times in an exclusive interview on Jan 9 at MG’s exhibition booth at Suntec Singapore Convention and Exhibition Centre, the 76-year-old motor tycoon is driven to take a ...

Nintendo revealed the Switch 2 via a several-minute-long YouTube trailer that showed off the new console's contours and a single Mario Kart game but little else. The Switch 2 was rumored for a ...

After seven years on the market, 146 million systems, and more than 1 billion games sold, Nintendo has finally announced the Nintendo Switch 2. The rumor mill was heating up in January ...

The little hybrid console that could had a great run, playing host to some all-time classic games – but its time is now running short: the Nintendo Switch 2 is official, and coming very soon. The firm ...